Whitehawk Therapeutics, Inc.
WHWK
$4.26
-$0.13-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 0.00 | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 0.00 | -- | -- |
| Cost of Revenue | 12.89M | 17.23M | 19.02M | 14.35M | 48.81M |
| Gross Profit | -12.89M | -17.23M | -19.02M | -14.35M | -48.81M |
| SG&A Expenses | 5.22M | 6.29M | 5.87M | 5.20M | 5.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.11M | 23.52M | 24.89M | 19.55M | 54.75M |
| Operating Income | -18.11M | -23.52M | -24.89M | -19.55M | -54.75M |
| Income Before Tax | -16.64M | -22.19M | -23.25M | -17.75M | -52.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.64M | -22.19M | -23.25M | -17.75M | -52.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.64M | -22.19M | -23.25M | -17.75M | -52.62M |
| EBIT | -18.11M | -23.52M | -24.89M | -19.55M | -54.75M |
| EBITDA | -18.11M | -23.52M | -24.89M | -19.54M | -54.73M |
| EPS Basic | -0.20 | -0.32 | -0.34 | -0.26 | -0.76 |
| Normalized Basic EPS | -0.13 | -0.20 | -0.21 | -0.16 | -0.48 |
| EPS Diluted | -0.20 | -0.32 | -0.34 | -0.26 | -0.76 |
| Normalized Diluted EPS | -0.13 | -0.20 | -0.21 | -0.16 | -0.48 |
| Average Basic Shares Outstanding | 82.89M | 69.24M | 69.21M | 69.20M | 69.08M |
| Average Diluted Shares Outstanding | 82.89M | 69.24M | 69.21M | 69.20M | 69.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |